Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Advanced Pharm > anticoags, antiplatelets, fibrinolytics > Flashcards

anticoags, antiplatelets, fibrinolytics Flashcards

1
Q

anticoagulant basic definition

A

prevent clot formation or extension of existing clot

have no effect after clot is formed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antiplatelet/antithrombotic basic definition

A

reduce PLT aggregation on the surface of the PLT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

thrombolytics/fibrinolytics

A

converts endogenous plasminogen to the fibrinolytic enzyme plasmin to dissolve newly formed blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the four major intrinsic anticoagulant mechanisms/pathways

A

fibrinolysis
tissue factor plasminogen inhibitor
protein C system
serine protease inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the main source of anticoagulation factors

A

the capillary endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

in what ways do we prevent blood coagulation outside the bodyo

A

siliconized containers
citrate ion (eats calcium)
heparin or CPB in artificial kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tissue factor plasminogen inhibitor

A

a polypeptide produced by endothelial cells that acts as a natural inhibitor of the the extrinsic pathway by inhibiting the TF-VIIa complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 4 key elements of the Protein C pathway

A

Protein C
thrombomodulin
endothelial protein C receptor
protein S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is protein C

A

an enzyme with potent anticoagulant, fibrinolytic, and anti-inflammatory properties that is activated by thrombin to form activated protein C (APC) and acts by inhibiting activated factors V and VIII (with protein S and phospholipids acting as cofactors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is thrombomodulin

A

a transmembrane receptor on the endothelial cells that prevents the formation of the clot in the undamaged endothelium by binding to the thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is endothelial protein C receptor

A

a transmembrane receptor that helps in the activation of protein C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is protein S

A

a vitamin K dependent glycoprotein, synthesized in the endothelial cells and hepatocytes

unbound form acts as a cofactor to APC in the inactivation of factor Va and VIIIa

bound form acts as an inhibitor of the complement system and is up-regulated in the inflammatory states which reduce the protein S levels, resulting in a pro-coagulant state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SERPIN

A

formerly known as antithrombin III and is the MAIN INHIBITOR OF THROMBIN

binds and inactivates thrombin, IIa, IXa, Xa, XIa, and XIIa

enzymatic activity is enhanced in the presence of heparin

synthesized in the liver and the plasma half life is 2.5-3.8 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SERPIN/AT3 deficiency

A

hereditary is 1 in 2,000-5,000

acquired (d/t prolonged heparin infusions >4-5days) shows decreased plasma AT activity by 50-60% of normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

citrate ion and anticoagulation

A

citrate deionizes calcium because it is negatively charged and it binds to the positively charged calcium to cause an un-ionized calcium compound

citrate ion is removed by the lier and polymerized into glucose or metabolized
**if there is liver damage or massive transfusion, the citrate ion might not be removed quickly enough and this can greatly depress the level of calcium ion in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the 5 types of anticoagulants listed on her slide

A 
vitamin K antagonist
 unfractionated heparin
low molecular weight heparin and fondaprinux
direct thrombin inhibitors
direct oral anticoagulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

coumadin/warfarin is what type of anticoagulant

A

vitamin K antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

mechanism of action of coumadin

A

inhibits vitamin K which results in hemostatically defective vitamin K dependent coagulation proteins (II, VII, IX, and X)

this is caused by competing with vitamin K for reactive sites in the enzymatic processes for formation of prothrombin and the other clotting factors, thereby blocking the action of vitamin k

platelet activity is not altered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

which are the vitamin K dependent clotting factors

A

II, VII, IX, X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

coumadin PK

A

rapidly and completely absorbed
97% protein bound
long elimination half time (24-36h) after PO
crosses placenta and is teratogenic so NO TO PREGNANT MOMS
metabolized into inactive metabolites that are conjugated and excreted in bile and urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

dosing of coumadin

A

2.5-10mg orally, dose varies

onset 3-4 days

single dose duration 2-4 days

effects seen on INR for 8-12 hours d/t depletion of factor VII, but full clinical effects are not appreciated for several days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how do you measure coumadin anticoagulation?

A

PT/INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what is your INR goal for a patient taking coumadin with A-fib, VTE, PE, tissue heart valve, or VTE prophylaxis?

A

2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is your INR goal in a patient with a mechanical heart valve, prevention of recurrent MI, history of VTE with INR 2-3

A

2.5-3.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
coumadin management before surgery
CHECK PT/INR minor surgery: d/c 1-5 days preop for PT 20% within baseline and restart 1-7 days post op immediate surgery (24-48h) or active bleeding: give vitamin K emergency: give FFP or 4-factor concentrate (Kcentra)
26
what is the dose of vit K for coumadin reversal
2.5-20mg orally or 1-5mg IV at a rate of 1mg/min PT to normal range within 4-24 hours
27
what is heparin and where does it come from
a naturally occurring polypeptide that inhibits coagulation it is released endogenously by mast cells and basophils and used widely as an anticoagulation drug
28
where does unfractionated heparin come from
derived from porcine intestine or bovine lung and is a mix of sulfated glycosaminioglycans that produce an anticoagulant effect by binding to and enhancing the naturally occurring effects of antithrombin **more predictable than LMWH
29
how does unfractionated heparin work
it binds to antithrombin and enhances the ability of antithrombin to inactive thrombin, Xa, XII, XI, and IX by 1000X accelerates the normally occurring antithrombin-induced neutralization of activated clotting factors long story short, decreased thrombin = decreased fibrin = decreased clotting
30
unfractionated heparin prepartions
large molecular weight only1/3 of what is administered binds to antithrombin to cause effect 1 unit of activity is the amount of heparin that maintains fluidity of 1 ml of citrated plasma for 1 hour after recalcification must contain at least 120 UPS units/ml
31
unfractionated heparin PK
poorly lipid soluble because it is large cannot cross lipid barriers or placenta - safe for OB circulates bound to plasma proteins which occurs instantly action is 1.5-4 hours decrease in body temp prolongs half time
32
what are the dose-response relationships for heparin?
100u/kg IV elimination half time = 56 minutes | 400u/kg IV elimination half time = 152 minutes
33
aPTT on heparin
should be 1.5 to 2.5 time longer than pre-drug(25-35s normal)
34
when to draw ACT on heparin
baseline 3-5 minutes post admin 30min-1hr intervals post admin
35
what are the three labs for monitoring unfractionated heparin
aPTT ACT HEPTEM
36
what are the clinical uses of heparin
SQ VTE and PE prophylaxis warfarin bridge vascular or non-CPB cases with goal ACT >200-300sec interventional aneurysm clipping/coiling with goal ACT>250sec CPB/ECMO with goal ACT>400-480sec (inadequate <180)
37
how would you dose unfractionated heparin for thromboembolism prophylaxis
5,000u SQ every 8-12 hours
38
unfractionated heparin dosing for treatment of thromboembolism
5,000u SQ followed by continuous gtt for goal PTT 1.5-2.5X control
39
unfractionated heparin dosing for CPB/ECMO
400u/kg IV
40
unfractionated heparin dosing for vascular interventions
100-150u/kg
41
heparin side effects
``` hemorrhage/hematomas HIT allergic reaction hypotension with large doses altered protein binding chronic exposure can progress to reduction of antithrombin activity ```
42
incidence of intraspinal hematoma
0.1 per 100,000 patients per year more likely to occur in anticoagulated or thrombocytopenic patients, those with neoplastic disease, liver disease, or alcoholism
43
IV heparin and neuraxial anesthesia
1 hour delay between needle placement and heparin administration catheter should be removed for 1 hour before heparin administration and 2-4 hours after last dose monitor PTT or ACT
44
heparin induced thrombocytopenia
heparin dependent antibodies that aggregate platelets and leads to consumption which produces thrombocytopenia
45
mild/type I HIT
30-40% of heparin treated patients non immune mediated plt count <100,000 cells/mm3 typically presents in 3-15 days after initiation of therapy
46
severe/type II HIT
0.5-6% of heparin treated patients immune mediated plt count <50,000 cell/mm3 present 6-10 days after initiation of therapy
47
how do you confirm HIT in patients with low platelet counts that you suspect this disease
lab tests for presence of antibodies
48
antithrombin deficiency and heparin
patients with this will have resistance to heparin because heparin binds to AT this occurs in up to 22% of patients undergoing cardiac surgery common in patients who receive intermittent or continuous heparin therapy estrogen also decreases heparin's ability to bind to AT you can treat this by restoring normal values with 2-4u FFP in adults or antithrombin concentrate
49
what is the reversal for heparin
protamine or FFP
50
what is the dose of protamine?
1-1.5mg for each 100u of heparin administered
51
low molecular weight heparins
derived from standard commercial grade unfractionated heparins by chemical depolymerization to yield fragments approximately 1/3 the size of heparin the depolymerization results in changes to the anticoagulant profile, PK, and effects on platelet function
52
differences in LMWH to unfractionated heparin (there are 4)
anti-activated factor X to anti-activated factor II activity: - LMWH: 4:1-2:1 - unfract: 1:1 molecular weight: - LMWH: 4,000-5,000 Daltons - unfract: 30,000 Daltons protein binding: - LMWH: less strong - unfract: strongly elimination half life/dosing: - LMWH: 24h/once daily - unfract: 2-3h/8-12h(BID-TID)
53
lovenox
binds to and accelerates antithrombin and inhibits factor Xa and factor IIa = decreased thrombin activity and prevention of fibrin clot formation used for DVT prophylaxis
54
dose of lovenox dvt prophylaxis
30mg SQ every 12h
55
advantages of using a LMWH like lovenox
``` reduced dosing frequency lack of need for monitoring more predictable PK fewer effects on platelet function reduced risk for HIT ```
56
disadvantages of using a LMWH like lovenox
more expensive surgery must be delayed for 12h after last dose protamine only neutralizes about 65% of anti-factor X activity, so a more complete reversal requires FFP
57
direct oral anticoagulants are used for
alternatives to warfarin treatment of VTE prevention of embolic stroke prophylaxis in patients undergoing surgery
58
what are the DOACs approved in most countries
direct thrombin inhibitor (IIa) - dabigatran | direct factor Xa inhibitor - rivaroxaban, apixaban, edoxaban
59
advantages of DOACs
rapid onset with peak effect in 2-4h predictable PK/PD minimal drug interactions no required routine lab monitoring
60
dabigatran (pradaxa)
direct thrombin (IIa) inhibitor metabolized via renal elimination half life is 12 hours unless reduced renal function monitor via coagulation assay reverse with idarucizumab (praxbind)
61
what is included in a coagulation assay
dilute thrombin time (more reliable and precise) aPTT (normal does not mean no residual anticoag effects) ROTEM (might correlate but less specific than dilute thrombin time)
62
idarucizumab - praxbind
this is an antidote for pradaxa aka dabigatran binds to dabigatran with 350X more affinity than thrombin half life is 45 minutes
63
factor Xa inhibitors name them
rivaroxaban (xarelto) apixaban (eliquis) edoxaban (savaysa)
64
metabolism of direct factor xa inhibitors
hepatic
65
monitoring for direct factor Xa inhibitors
coagulation assay - anti-xa (not widely available) ROTEM is not sensitive PT can be a helpful indicator of rivaroxaban only
66
general management of DOAC-treated patients undergoing surgery
minimal bleeding risk procedures are likely to undergo with no DOAC interruptions low bleeding risk procedures - stop DOAC for 24h prior to elective surgery high bleeding risk procedures - stop DOAC for 48h prior to elective surgery
67
what is the reversal for dabigatran
idarucizumab
68
what is the reversal for apixaban and rivaroxaban?
andexanet alfa
69
what is the reversal for vitamin K antagonists
PCC - prothrombin compex concentrates
70
what are the antiplatelet agents
cox inhibitors P2Y12 receptor antagonists GP IIb/IIIa inhibitors
71
antiplatelets
suppress platelet function (aka inhibit platelet aggregation) for the prevention of thrombosis
72
when is antiplatelet therapy indicated
for patients at risk for CVA, MI, or other vascular thrombosis complications
73
asprin
inhibits platelet aggregation by inhibiting thromboxane A2 synthesis by interfering with cox and the subsequent release of ADP by platelets and their aggregation effects are irreversible and last the life of the platelet (8-12 days)
74
what is the dose of aspirin
81-325mg
75
how does aspirin work
cox is rendered non-functional because the acetyl group of ASA causes acetylation of cox which is the enzyme that converts arachidonic acid to thromboxane
76
NSAIDs
ketorolac, naprosyn, ibuprofen same MOA as aspirin but they reversibly depress thromboxane A2 so effects are only 24-48h and are often held prior to surgery
77
how to manage ASA in periop period
primary prophylaxis: ASA should be continued in periop period for up to and including day of procedure, but could be held for a few days at discretion of surgeon - think patients with hyperlipidemia but no established CV disease secondary prophylaxis: ASA should be continued in periop period for up to and including day of procedure, and should not be stopped unless there has been an explicit discussion with their cardiac/vascular physician to establish cardiac risk vs bleeding risk - think patients with a-fib, previous MI, stent HOLD ASA for intracranial, middle ear, posterior eye, or intramedullary spine surgery, possibly in prostate surgery and DOCUMENT decision
78
P2Y12 receptor antagonist MOA
inhibitors of platelet activation and aggregation through the irreversible binding of its active metabolite to the to the P2Y12 class of ADP receptors on platelets
79
clopidrogel
aka plavix P2Y12 receptor antagonist this is a pro-drug and must be metabolized by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation for the life of the platelet
80
ticagrelor
aka brillinta P2Y12 receptor antagonist does not need hepatic activation and might work better for pateints with genetic variants better mortality rates in treating patients with ACS
81
how long must you hold P2Y12 inhibitors?
7 days prior to elective surgery
82
if your patient is having emergency surgery and they are on a P2Y12 inhibitor, what could you do?
platelet transfusion
83
indications for P2Y12 antagonists
``` secondary prevention of MI, CVA coronary artery stenting ACS PAD PCI ```
84
PCI and stent placement
PCI causes endothelial and medial damage that heals by neointimal formation usually within 2-6 weeks with BMS DES - this healing is delayed which can cause risk for platelet aggregation and thrombus formation, so they are usually anticoagulated for up to a year elective surgery should be delayed by at least 6-12 months following DES placement
85
if you see a patient taking aspirin and plavix what should you think
ASA and P2Y12 antagonists act synergistically so they are going to be a high bleed risk
86
over 10% or ACS in periop period is associated with what
preop cessation of ASA
87
how long are patients with stents at a high risk of thrombotic events?
the first 3 months after insertion
88
platelet GP IIa/IIIb antagonists MOA
act at the corresponding fibrinogen receptor that is important for platelet aggregation to block fibrinogen which is the final common pathway of platelet aggregation
89
when are GP IIa/IIIb antagonists used
ACS, angioplasty failures, stent thrombosis
90
what are the GP IIa/IIIb antagonists
abciximab (reopro) tirofiban (aggrastat) eptifibatide (integrilin)
91
how to monitor GP IIa/IIIb antagonists
ACTs (maintained between 200-400sec) platelet counts - d/c if thrombocytopenia (<100,000 cells/mm3) develops
92
how do you reverse the effects of GP IIa/IIIa antagonists?
platelet transfusions
93
what are the herbal anticoagulants
``` garlic gingko ginseng black cohosh fish oil feverfew ```
94
garlic
inhibits platelet aggregation - d/c for seven days
95
gingko
inhibits platelet activating factor - d/c for 36h
96
ginseng
inhibits platelet aggrevation and lowers blood glucose check PT/PTT/glucose d/c for 24h but preferably 7 days
97
black cohosh
claims to be useful for menopausal symptoms contains small amounts of anti-inflammatory compounds including salicylic acid
98
fish oil
claims to prevent/treat atherosclerotic CV disease (800-1500mg/day) also used to treat triglycerides (>4g/day) dose-dependent bleeding risk with >3g/day
99
feverfew
claims to prevent migraines increases the risk of bleeding because it individually inhibits platelet aggregation has additive effects with other antiplatelet drugs and additive effects with warfarin
100
plasminogen
a serum protein that is absorbed into the clot as it forms it is cleaved into plasmin which breaks down the fibrin and fibrinogen of a clot activated by t-PA and urokinase-type-PA
101
which thrombolytics are fibrin specific and which are non-fibrin specific
fibrin specific: alteplase, reteplase, tenecteplase non-fibrin specific: streptokinase
102
thrombolytics
possess inherent fibrinolytic effects or enhances the body's fibrinolytic system by converting the endogenous pro-enzyme plasminogen to the fibrinolytic enzyme plasmin they are more capable of dissolving newly formed clots which are platelet rich and have weaker fibrinogen bonds
103
why do we use thrombolytics
to restore circulation through a previously occluded vessel - STEMI - acute ischemic stroke - acute massive PE
104
when are thrombolytics contraindicated
trauma, severe HTN, active bleeding, pregnancy
105
what is the most common risk of thrombolytics
hemorrhage or bleeding
106
what is the window from event time to giving a thrombolytic
6 hours
107
alteplase (recombinant tissue plasminogen activator)
a fibrin-specific thrombolytic drug synthesized by endothelial cells limited to use int he first 3-6h of ischemic stroke can be administered systemically or directly into embolism t1/2 5 minutes - usually administered as a bolus and then infusion
108
streptokinase
protein produced by beta-hemolytic streptococci it is not an enzyme it non-covalently bonds to plasminogen and converts it to a plasminogen activator complex that acts on other plasminogen molecules to generate plasmin it is the lease expensive of the thrombolytics but since it is made from bacteria, antibodies may form and you could have allergic reaction
109
what are the thrombolytic therapy adverse effects
bleeding re-thrombosis so administer with other anticoagulants that are longer acting
110
what does the efficacy of thrombolytic therapy depend upon
age of clot older clots have more crosslinking and are more compacted so they are more difficult to dissolve

Advanced Pharm (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions